Ataxin Antibodies

Santa Cruz Biotechnology features a diverse variety of Ataxin monoclonal antibodies for research in neurodegenerative diseases and cellular signaling pathways. Ataxin Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ataxins are a family of proteins associated with the regulation of neuronal function and play a crucial role in the pathogenesis of spinocerebellar ataxias, a group of inherited neurodegenerative disorders. Understanding Ataxin function is essential for elucidating the molecular mechanisms underlying these conditions and for developing potential therapeutic strategies. The study of Ataxins provides valuable insights into broader cellular processes, including gene expression and protein interactions. Researchers can explore specific Ataxin variants and their distribution patterns in different tissues and cellular compartments. Advanced research techniques allow for detailed analysis of Ataxin expression levels and modifications in various experimental conditions. The investigation of Ataxin-related pathways contributes to a deeper understanding of neurodegenerative disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge in neurodegenerative disease research and potential therapeutic developments.